278 related articles for article (PubMed ID: 16501291)
1. Clinical significance of the electrophysiologic study (EPS)-guided therapy for the secondary prevention of ventricular tachycardia.
Yuge M; Niwano S; Moriguchi M; Sasaki T; Hirasawa S; Imaki R; Sato D; Izumi T
Circ J; 2006 Mar; 70(3):268-72. PubMed ID: 16501291
[TBL] [Abstract][Full Text] [Related]
2. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
AbdelWahab A; Sapp J
Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
[TBL] [Abstract][Full Text] [Related]
3. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
[TBL] [Abstract][Full Text] [Related]
4. Ventricular tachyarrhythmia recurrence in primary versus secondary implantable cardioverter-defibrillator patients and role of electrophysiology study.
Zaman S; Sivagangabalan G; Chik W; Stafford W; Hayes J; Denman R; Young G; Sanders P; Kovoor P
J Interv Card Electrophysiol; 2014 Dec; 41(3):195-202. PubMed ID: 25267274
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiologic parameters to predict clinical recurrence of ventricular tachycardia in patients under electrophysiologic study-guided effective pharmacological therapy.
Niwano S; Yamaura M; Yoshizawa N; Moriguchi M; Kitano Y; Aizawa Y; Izumi T
Jpn Circ J; 1999 Sep; 63(9):674-80. PubMed ID: 10496481
[TBL] [Abstract][Full Text] [Related]
6. Clinical and electrophysiologic predictors of ventricular tachyarrhythmia recurrence in patients with implantable cardioverter defibrillators.
Gillis AM; Sheldon RS; Wyse DG; Duff HJ; Cassidy MR; Mitchell LB
J Cardiovasc Electrophysiol; 2003 May; 14(5):492-8. PubMed ID: 12776866
[TBL] [Abstract][Full Text] [Related]
7. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
[TBL] [Abstract][Full Text] [Related]
8. Role of electrophysiologic study (EPS)-guided preventive therapy for the management of ventricular tachyarrhythmias in patients with heart failure.
Niwano S; Fukaya H; Yuge M; Imaki R; Hirasawa S; Sasaki T; Yumoto Y; Inomata T; Izumi T
Circ J; 2008 Feb; 72(2):268-73. PubMed ID: 18219165
[TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol.
Leite LR; Fenelon G; Simoes A; Silva GG; Friedman PA; de Paola AA
J Cardiovasc Electrophysiol; 2003 Jun; 14(6):567-73. PubMed ID: 12875414
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic Support in Ventricular Tachycardia Ablation: An International VT Ablation Center Collaborative Group Study.
Turagam MK; Vuddanda V; Atkins D; Santangeli P; Frankel DS; Tung R; Vaseghi M; Sauer WH; Tzou W; Mathuria N; Nakahara S; Dickfeld TM; Bunch TJ; Weiss P; Di Biase L; Tholakanahalli V; Vakil K; Tedrow UB; Stevenson WG; Della Bella P; Shivkumar K; Marchlinski FE; Callans DJ; Natale A; Reddy M; Lakkireddy D
JACC Clin Electrophysiol; 2017 Dec; 3(13):1534-1543. PubMed ID: 29759835
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
[TBL] [Abstract][Full Text] [Related]
12. Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.
Raitt MH; Klein RC; Wyse DG; Wilkoff BL; Beckman K; Epstein AE; Coromilas J; Friedman PL; Martins J; Ledingham RB; Greene HL;
Am J Cardiol; 2003 Apr; 91(7):812-6. PubMed ID: 12667566
[TBL] [Abstract][Full Text] [Related]
13. [Eleven-years long follow-up in a patient after myocardial infarction, with low ejection fraction and recurrent ventricular tachycardia. The role of implantable cardioverter defibrillator and selective ablation].
Przybylski A; Derejko P; Iwanek M; Urbanek P; Kepski R; Grzybowski J; Chojnowska L; Szumowski Ł; Szwed H; Walczak F
Kardiol Pol; 2006 Jul; 64(7):758-62. PubMed ID: 16886137
[TBL] [Abstract][Full Text] [Related]
14. Significance of repeat programmed ventricular stimulation at electrophysiology study for arrhythmia prediction after acute myocardial infarction.
Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P
Pacing Clin Electrophysiol; 2014 Jul; 37(7):795-802. PubMed ID: 24666010
[TBL] [Abstract][Full Text] [Related]
15. Postoperative ventricular arrhythmias after cardiac surgery: immediate- and long-term significance.
Brembilla-Perrot B; Villemot JP; Carteaux JP; Haouzi A; Amrein D; Schöth B; Houriez P; Beurrier D; Djaballah K; Vançon AC; Nippert M
Pacing Clin Electrophysiol; 2003 Feb; 26(2 Pt 1):619-25. PubMed ID: 12710323
[TBL] [Abstract][Full Text] [Related]
16. Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): A Multicenter Randomized Trial.
Willems S; Tilz RR; Steven D; Kääb S; Wegscheider K; Gellér L; Meyer C; Heeger CH; Metzner A; Sinner MF; Schlüter M; Nordbeck P; Eckardt L; Bogossian H; Sultan A; Wenzel B; Kuck KH;
Circulation; 2020 Mar; 141(13):1057-1067. PubMed ID: 32000514
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic decision tree for patients with sustained ventricular tachyarrhythmias or aborted cardiac arrest: a critical review of the Antiarrhythmics Versus Implantable Defibrillator trial and the Canadian Implantable Defibrillator Study.
Farré J; Cabrera JA; Romero J; Rubio JM
Am J Cardiol; 2000 Nov; 86(9A):44K-51K. PubMed ID: 11084100
[TBL] [Abstract][Full Text] [Related]
19. Clinical usefulness of electrophysiologic study (EPS)-guided risk stratification for life-threatening arrhythmia in patients with heart failure.
Sasaki S; Niwano S; Fukaya H; Yuge M; Imaki R; Inomata T; Izumi T
Int Heart J; 2007 Mar; 48(2):155-63. PubMed ID: 17409581
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic catheter ablation for induced monomorphic ventricular tachycardia in patients with implantable cardioverter defibrillators as primary prevention.
Hayashi T; Fukamizu S; Hojo R; Komiyama K; Tanabe Y; Tejima T; Soejima K; Nishizaki M; Hiraoka M; Ako J; Momomura S; Sakurada H
Europace; 2013 Oct; 15(10):1507-15. PubMed ID: 23603305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
